Literature DB >> 21206122

Idiopathic pulmonary hemosiderosis: alveoli are an answer to anemia.

S Bhatia1, M S Tullu, P Vaideeswar, K R Lahiri.   

Abstract

Idiopathic pulmonary hemosiderosis (IPH) is a rare disorder (triad of iron-deficiency anemia, hemoptysis, and alveolar infiltrates). A 3-year-old male presented with mild fever, breathlessness, dry cough, and bluish nail discoloration for 8 days. He had required five blood transfusions in the past 1 year (last transfusion was given 4 months ago). He had a respiratory rate of 58/min with respiratory distress, cyanosis, and grade III clubbing. Respiratory system examination was normal. Several previous reports of hemoglobin were as low as 3.6 g/dl with hypochromic and microcytic anemia. There were transient increases in the hemoglobin and normalization of red cell morphology with blood transfusions. Serum iron, G6PD enzyme assay, hemoglobin electrophoresis, the sickling test, Coomb's test, stool and urine analysis, and a Meckel's scan were normal. HIV antibody and dsDNA were negative. The chest radiograph revealed symmetrical patchy infiltrates sparing lung apices (confirmed on high-resolution computed tomography). Lung biopsy diagnosed pulmonary hemosiderosis (interstitial lung disease with hemosiderin-laden macrophages scattered in the alveoli and areas of fibrosis in the alveolar septa). The patient showed marked clinical improvement in 10 days of therapy with prednisolone. IPH should be listed in the differential diagnosis of a child presenting with unexplained hypochromic, microcytic anemia and respiratory symptoms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21206122     DOI: 10.4103/0022-3859.74290

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN: 0022-3859            Impact factor:   1.566


  4 in total

1.  Pulmonary Hemosiderosis in a Child With Systemic Lupus Erythematosus: A Rare Presentation.

Authors:  Nikhil Rajvanshi; Swathi Chacham; Madhuradhar Chegondi; Jagdish P Goyal; Surjit Singh
Journal:  Cureus       Date:  2020-04-29

2.  Use of Corticosteroids in the management of Idiopathic Pulmonary Haemosiderosis: Do we have enough evidence.

Authors:  Ammara Mushtaq; Subika Khatoon; Muhammad Asif Qureshi
Journal:  Pak J Med Sci       Date:  2015 Mar-Apr       Impact factor: 1.088

3.  New insights into pediatric idiopathic pulmonary hemosiderosis: the French RespiRare(®) cohort.

Authors:  Jessica Taytard; Nadia Nathan; Jacques de Blic; Mickael Fayon; Ralph Epaud; Antoine Deschildre; Françoise Troussier; Marc Lubrano; Raphaël Chiron; Philippe Reix; Pierrick Cros; Malika Mahloul; Delphine Michon; Annick Clement; Harriet Corvol
Journal:  Orphanet J Rare Dis       Date:  2013-10-14       Impact factor: 4.303

4.  Clinical characteristics and prognosis of idiopathic pulmonary hemosiderosis in pediatric patients.

Authors:  Yajun Zhang; Fenglan Luo; Nini Wang; Yue Song; Yuhong Tao
Journal:  J Int Med Res       Date:  2018-10-02       Impact factor: 1.573

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.